MEDISTIM ASA (MEDI.OL) Stock Fundamental Analysis
OSL:MEDI - Euronext Oslo - NO0010159684 - Common Stock - Currency: NOK
Taking everything into account, MEDI scores 6 out of 10 in our fundamental rating. MEDI was compared to 58 industry peers in the Health Care Equipment & Supplies industry. MEDI gets an excellent profitability rating and is at the same time showing great financial health properties. MEDI is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
MEDI had positive earnings in the past year.
In the past year MEDI had a positive cash flow from operations.
Each year in the past 5 years MEDI has been profitable.
In the past 5 years MEDI always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 18.06%, MEDI belongs to the top of the industry, outperforming 94.83% of the companies in the same industry.
MEDI has a Return On Equity of 23.78%. This is amongst the best in the industry. MEDI outperforms 91.38% of its industry peers.
With an excellent Return On Invested Capital value of 21.60%, MEDI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for MEDI is significantly above the industry average of 8.41%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.06% | ||
| ROE | 23.78% | ||
| ROIC | 21.6% |
ROA(3y)20.73%
ROA(5y)20.96%
ROE(3y)26.96%
ROE(5y)27.52%
ROIC(3y)24.89%
ROIC(5y)25.57%
1.3 Margins
MEDI's Profit Margin of 18.46% is amongst the best of the industry. MEDI outperforms 89.66% of its industry peers.
In the last couple of years the Profit Margin of MEDI has remained more or less at the same level.
The Operating Margin of MEDI (23.30%) is better than 93.10% of its industry peers.
In the last couple of years the Operating Margin of MEDI has remained more or less at the same level.
MEDI's Gross Margin of 79.79% is amongst the best of the industry. MEDI outperforms 91.38% of its industry peers.
MEDI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.3% | ||
| PM (TTM) | 18.46% | ||
| GM | 79.79% |
OM growth 3Y-5.05%
OM growth 5Y-1.15%
PM growth 3Y-4.63%
PM growth 5Y-0.92%
GM growth 3Y1.08%
GM growth 5Y0.46%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MEDI is creating value.
Compared to 1 year ago, MEDI has about the same amount of shares outstanding.
Compared to 5 years ago, MEDI has more shares outstanding
Compared to 1 year ago, MEDI has a worse debt to assets ratio.
2.2 Solvency
The Debt to FCF ratio of MEDI is 0.21, which is an excellent value as it means it would take MEDI, only 0.21 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.21, MEDI belongs to the best of the industry, outperforming 98.28% of the companies in the same industry.
A Debt/Equity ratio of 0.06 indicates that MEDI is not too dependend on debt financing.
MEDI has a Debt to Equity ratio of 0.06. This is amongst the best in the industry. MEDI outperforms 94.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.21 | ||
| Altman-Z | N/A |
ROIC/WACC2.54
WACC8.51%
2.3 Liquidity
MEDI has a Current Ratio of 4.00. This indicates that MEDI is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of MEDI (4.00) is better than 87.93% of its industry peers.
MEDI has a Quick Ratio of 2.50. This indicates that MEDI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.50, MEDI belongs to the top of the industry, outperforming 84.48% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4 | ||
| Quick Ratio | 2.5 |
3. Growth
3.1 Past
MEDI shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.06%.
MEDI shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.58% yearly.
Looking at the last year, MEDI shows a small growth in Revenue. The Revenue has grown by 6.88% in the last year.
MEDI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.06% yearly.
EPS 1Y (TTM)-0.06%
EPS 3Y14.25%
EPS 5Y12.58%
EPS Q2Q%11.54%
Revenue 1Y (TTM)6.88%
Revenue growth 3Y13.17%
Revenue growth 5Y10.06%
Sales Q2Q%11.44%
3.2 Future
The Earnings Per Share is expected to grow by 6.40% on average over the next years.
The Revenue is expected to grow by 6.71% on average over the next years.
EPS Next Y7.04%
EPS Next 2Y1.53%
EPS Next 3Y3.37%
EPS Next 5Y6.4%
Revenue Next Year4.79%
Revenue Next 2Y7.39%
Revenue Next 3Y6.97%
Revenue Next 5Y6.71%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 36.51, which means the current valuation is very expensive for MEDI.
MEDI's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of MEDI to the average of the S&P500 Index (26.20), we can say MEDI is valued slightly more expensively.
With a Price/Forward Earnings ratio of 35.42, MEDI can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, MEDI is valued a bit more expensive than the industry average as 60.34% of the companies are valued more cheaply.
MEDI's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.13.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.51 | ||
| Fwd PE | 35.42 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MEDI is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, MEDI is valued a bit cheaper than 72.41% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 32.06 | ||
| EV/EBITDA | 22.76 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
MEDI has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)5.19
PEG (5Y)2.9
EPS Next 2Y1.53%
EPS Next 3Y3.37%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.82%, MEDI has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.19, MEDI pays a better dividend. On top of this MEDI pays more dividend than 86.21% of the companies listed in the same industry.
MEDI's Dividend Yield is comparable with the S&P500 average which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.82% |
5.2 History
On average, the dividend of MEDI grows each year by 14.87%, which is quite nice.
Dividend Growth(5Y)14.87%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
79.37% of the earnings are spent on dividend by MEDI. This is not a sustainable payout ratio.
MEDI's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP79.37%
EPS Next 2Y1.53%
EPS Next 3Y3.37%
OSL:MEDI (5/28/2025, 7:00:00 PM)
207
+3 (+1.47%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners60.75%
Inst Owner ChangeN/A
Ins Owners2.83%
Ins Owner ChangeN/A
Market Cap3.80B
Analysts42.22
Price Target175.44 (-15.25%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.82% |
Yearly Dividend4.5
Dividend Growth(5Y)14.87%
DP79.37%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-19.77%
Min EPS beat(2)-21.02%
Max EPS beat(2)-18.51%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.33%
Min Revenue beat(2)-4.3%
Max Revenue beat(2)8.95%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-4.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)7.31%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.51 | ||
| Fwd PE | 35.42 | ||
| P/S | 6.75 | ||
| P/FCF | 32.06 | ||
| P/OCF | 26.53 | ||
| P/B | 8.7 | ||
| P/tB | 10.06 | ||
| EV/EBITDA | 22.76 |
EPS(TTM)5.67
EY2.74%
EPS(NY)5.84
Fwd EY2.82%
FCF(TTM)6.46
FCFY3.12%
OCF(TTM)7.8
OCFY3.77%
SpS30.68
BVpS23.81
TBVpS20.57
PEG (NY)5.19
PEG (5Y)2.9
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.06% | ||
| ROE | 23.78% | ||
| ROCE | 28.03% | ||
| ROIC | 21.6% | ||
| ROICexc | 35.03% | ||
| ROICexgc | 44.1% | ||
| OM | 23.3% | ||
| PM (TTM) | 18.46% | ||
| GM | 79.79% | ||
| FCFM | 21.05% |
ROA(3y)20.73%
ROA(5y)20.96%
ROE(3y)26.96%
ROE(5y)27.52%
ROIC(3y)24.89%
ROIC(5y)25.57%
ROICexc(3y)39.99%
ROICexc(5y)39.99%
ROICexgc(3y)48.52%
ROICexgc(5y)48.01%
ROCE(3y)32.29%
ROCE(5y)33.19%
ROICexcg growth 3Y-6.52%
ROICexcg growth 5Y0.36%
ROICexc growth 3Y-8.47%
ROICexc growth 5Y0.04%
OM growth 3Y-5.05%
OM growth 5Y-1.15%
PM growth 3Y-4.63%
PM growth 5Y-0.92%
GM growth 3Y1.08%
GM growth 5Y0.46%
F-Score4
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.21 | ||
| Debt/EBITDA | 0.16 | ||
| Cap/Depr | 100.75% | ||
| Cap/Sales | 4.39% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 91.98% | ||
| Profit Quality | 114.04% | ||
| Current Ratio | 4 | ||
| Quick Ratio | 2.5 | ||
| Altman-Z | N/A |
F-Score4
WACC8.51%
ROIC/WACC2.54
Cap/Depr(3y)105.67%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.78%
Cap/Sales(5y)N/A
Profit Quality(3y)91.83%
Profit Quality(5y)103.03%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.06%
EPS 3Y14.25%
EPS 5Y12.58%
EPS Q2Q%11.54%
EPS Next Y7.04%
EPS Next 2Y1.53%
EPS Next 3Y3.37%
EPS Next 5Y6.4%
Revenue 1Y (TTM)6.88%
Revenue growth 3Y13.17%
Revenue growth 5Y10.06%
Sales Q2Q%11.44%
Revenue Next Year4.79%
Revenue Next 2Y7.39%
Revenue Next 3Y6.97%
Revenue Next 5Y6.71%
EBIT growth 1Y-0.28%
EBIT growth 3Y4.07%
EBIT growth 5Y7.86%
EBIT Next Year10%
EBIT Next 3Y10.15%
EBIT Next 5YN/A
FCF growth 1Y41.87%
FCF growth 3Y-0.65%
FCF growth 5Y12.16%
OCF growth 1Y26.43%
OCF growth 3Y3.75%
OCF growth 5Y12.23%